The CAR-T Treatment Market has gained substantial attention in the field of oncology, offering groundbreaking solutions for treating aggressive and treatment-resistant cancers. Chimeric Antigen Receptor T-cell (CAR-T) therapy modifies a patient's own T-cells to identify and destroy cancer cells effectively. With multiple therapies already approved and ongoing clinical trials showing...